Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide
Andreas Brønden,
Filip K Knop
,
Mikkel B Christensen
Department of Clinical Medicine
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Pharmacology
100%
Albiglutide
100%
Pharmacodynamics
100%
Placebo
33%
Glucagon-like
25%
A1 Receptor
25%
Type 2 Diabetes Mellitus (T2DM)
16%
Receptor Agonist
16%
Vomiting
8%
Recommended Dose
8%
Adverse Events
8%
Liraglutide
8%
Pharmacodynamic Properties
8%
Pancreatitis
8%
Clinical Trials
8%
Antihyperglycemic
8%
Type 2 Diabetes Prevention
8%
Once-weekly Administration
8%
Subcutaneous Administration
8%
Fasting Plasma Glucose
8%
Clinical Safety
8%
Europe
8%
Renal Function
8%
Weight Reduction
8%
Receptor Activation
8%
Nausea
8%
Cardiovascular Outcome Trials
8%
Risk-benefit
8%
Safety Profile
8%
Pharmacokinetic Properties
8%
Glycated Hemoglobin
8%
Once-weekly
8%
Active Comparator
8%
Safety Data
8%
Efficacy Data
8%
Elimination Half-life
8%
Clinical Efficacy
8%
Diarrhea
8%
Pharmacology, Toxicology and Pharmaceutical Science
Albiglutide
100%
Clinical Pharmacokinetics
100%
Pharmacodynamics
100%
Placebo
33%
Glucagon Like Peptide 1 Receptor Agonist
16%
Non Insulin Dependent Diabetes Mellitus
16%
Subcutaneous Injection
8%
Liraglutide
8%
Nausea
8%
Diarrhea
8%
Glucagon-Like Peptide 1 Receptor
8%
Adverse Event
8%
Glycosylated Hemoglobin
8%
Pancreatitis
8%
Pharmacokinetic
8%
Clinical Trial
8%
Elimination
8%